Search Results

Revvity Signals helps take advantage of AI-ready data within antibody drug discovery. Learn how Signals Research Suite can help accelerate scientific.

Signals One™ has RNA specific tools for leading biopharmaceutical companies to make data-driven decisions. Learn how we meet chemists and RNA biologists needs.

Therapeutics discovery relies on multiple, complementary analytical techniques to best position new drug candidates for commercial success. Various assay technologies are utilized in the wet lab for their respective strengths. Combining two or more methodologies with different selectivity (an orthogonal approach or orthogonal method which uses fundamentally...

Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, Revvity Signals. The move will support the integration of the Revvity Signals One™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory instruments...

Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.

Learn about techniques such as Protacs and molecular glues. Explore Revvity's blog for more insights about how researchers are targeting the undruggable

Signals Image Artist is an advanced image analysis software for high-content screening and cell imaging data. Analyze, visualize and share your results with ease.

Pharmaceutical and biotechnology companies face many changes if the Biosecure Act passes into law. Learn how Revvity Signals solutions, such as Signals Synergy can aid the biotechnology sector.

Read on more about the collaboration between Revvity Signals and TetraScience. See how this partnership can facilitate faster and better scientific decision-making.